Danaher Corporation with price, financials, news flow, and insider context in one page.
Danaher Corporation is being tracked here through price action, operating context, and headline flow. This public page covers the latest market move, where DHR sits inside Healthcare and Diagnostics & Research, and the key financial markers that matter before moving into a fuller research workflow.
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
This page is structured for research context, not a trade call. It gives you a clean read on where DHR sits in its range, what the last few quarters look like, and which headlines are shaping attention.
For position sizing, alerts, saved watchlists, and deeper analysis workflows, the next step is the logged-in Meridian workspace.
| Quarter | Revenue | Net income | Free cash flow |
|---|---|---|---|
| Q1 2026 | 5.95B | 1.03B | 1.09B |
| Q4 2025 | 6.84B | 1.2B | 1.75B |
| Q3 2025 | 6.05B | 908M | 1.37B |
| Q2 2025 | 5.94B | 555M | 1.09B |
Recent insider transaction detail is not available for this symbol right now.
See the next report date, earnings cadence, and reporting context.
Open a side-by-side comparison page to frame valuation and growth.
Read open desk notes tied to sectors, macro themes, and active names.
Learn the framework behind valuation, momentum, and risk before you act.
Danaher Corporation (DHR) — questions investors ask
What is the current stock price of Danaher Corporation (DHR)?
Danaher Corporation (DHR) is trading at $196.16, up 1.53% in the latest session. The live price and one-year chart on this page update through the trading day.
What is Danaher Corporation's market capitalization?
Danaher Corporation has a market capitalization of about 138.86B, derived from the latest share price and shares outstanding.
When is Danaher Corporation's next earnings date?
Danaher Corporation is next expected to report earnings on Jul 21, 2026. The DHR earnings page tracks the estimate and reporting history.
What is Danaher Corporation's P/E ratio?
Danaher Corporation trades at a forward price-to-earnings ratio of 21.3 — one measure of how the market is pricing its future earnings.
What is DHR's 52-week trading range?
Over the past 52 weeks, DHR has traded between $160.93 and $242.80.
What sector is Danaher Corporation in?
Danaher Corporation operates in the Healthcare sector, within the Diagnostics & Research industry.
Does Danaher Corporation pay a dividend?
Danaher Corporation currently carries a dividend yield of about 82.0%.
What is the analyst price target for DHR?
The mean analyst price target for DHR is $242.35, with an overall analyst view of Strong Buy.
A public stock page should answer the first research questions before asking for a signup.
This DHR page is designed for public research utility. You can read the latest session move, check the one-year chart, review a compact financial table, scan recent headlines, and compare adjacent names without immediately moving into a gated dashboard.
The logged-in Meridian workflow goes further with saved watchlists, deeper analysis, alert routing, and recurring review systems. The public layer is meant to be credible and indexable on its own, not a hollow teaser page.